First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera

被引：0
|
作者：
Griesshammer, M. [1 ]
von der Heyde, E. [2 ]
Weide, R. [3 ]
Reichert, D. [4 ]
Weniger, J. [5 ]
Schlag, R.
Hutzschenreuter, U. [6 ]
Becker, M. [7 ]
Just, M.
Hacker, E. [8 ]
Cavanna, D. [8 ]
Lengfelder, E. [9 ]
机构：
[1] Johannes Wesling Klinikum, Minden, Germany
[2] Gemeinschaftspraxis Dres Zander von der Heyde, Hannover, Germany
[3] Praxisklin Hamatol & Onkol, Koblenz, Germany
[4] Onkol Gemeinschaftspraxis Dres Reichert Janssen, Westerstede, Germany
[5] Gemeinschaftspraxis Hamatol & Onkol Dres Weniger, Erfurt, Germany
[6] Hamatol Onkol Gemeinschaftspraxis Dres Hutzschenr, Nordhorn, Germany
[7] Zentrum Hamatol & Onkol MVZ GmbH, Porta Westfalica, Germany
[8] Novartis Pharma GmbH, Nurnberg, Germany
[9] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P544
引用
收藏
页码：148 / +
页数：2
相关论文
共 50 条
  • [1] Interim analysis results from the prospective, non-interventional study of ruxolitinib in patients with polycythemia vera (PAVE): safety results were consistent with previous findings
    Griesshammer, M.
    Kaempfe, D.
    Weide, R.
    Reichert, D.
    Sauer, A.
    Doerfel, S.
    Koenigsmann, M.
    Stauch, M.
    Grosser, S.
    Zander, I.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 243 - 244
  • [2] Updated interim analysis of PAVE: a prospective, non-interventional study in Germany of ruxolitinib (RUX) in patients (Pts) with polycythaemia vera (PV)
    Griesshammer, M.
    Von der Heyde, E.
    Schlag, R.
    Schmidt, B.
    Weniger, S.
    Koenigsmann, M.
    Stauch, M.
    Baum, V.
    Weide, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 267 - 267
  • [3] First interim analysis of the German prospective, noninterventional study JAKoMo: First results on the daily clinical routine of ruxolitinib in Myelofibrosis
    Heinrich, B.
    Geer, T.
    Hochdoerfer, S.
    Jordan, W. O.
    Losem, C.
    Haug, D.
    Cavanna, D.
    Fritsche, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 62 - 62
  • [4] 2016 Interim analysis of the prospective, non-interventional study JAKoMo: new insights into ruxolitinib treatment of myelofibrosis in daily clinical routine
    Geer, T.
    Heinrich, B.
    Jacobasch, L.
    Tesch, H.
    Wehmeyer, J.
    Schlag, R.
    Groeschl, B.
    Markhauser, M.
    Bachhuber, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 149 - 149
  • [5] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 510 - 510
  • [6] Olaparib in German routine clinical practice - Interim results of the non-interventional study C-PATROL
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Fasching, P. A.
    El-Balat, A.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [7] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1590 - 1590
  • [8] USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS - RESULTS OF THE FIRST INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY SUSTAIN
    Wendler, J.
    Schwarze, I.
    Schwenke, H.
    Behrens, J.
    Gruppe, T.
    Behrens, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1322 - 1322
  • [9] Olaparib in German routine clinical practice: Updated interim results of the non-interventional study C-PATROL.
    Marme, Frederik
    Hilpert, Felix
    Welslau, Manfred
    El-Balat, Ahmed
    Grischke, Eva-Maria
    Schinkothe, Timo
    Glowik, Regina
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Glowik, R.
    Marme, F.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 120 - 120
12345